Skip to main content
. Author manuscript; available in PMC: 2013 May 3.
Published in final edited form as: Int J STD AIDS. 2012 May;23(5):351–355. doi: 10.1258/ijsa.2011.011292

Figure 1. Median VAS adherence by HAART regimen characteristics.

Figure 1

The four groups above are not mutually exclusive: the fixed dose combination EFV/FTC/TDF 1 pill once daily and the >1 pill, once daily groups are part of the once daily group